Impact of CardiolRxTM on Recurrent Pericarditis: An open label Pilot Study
Cardiol 100-004
Phase 1 other active
Quick answer
Impact of CardiolRxTM on Recurrent Pericarditis: An open label Pilot Study for Recurrent Pericarditis is a Phase 1 program (other) at Cardiol Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cardiol Therapeutics
- Indication
- Recurrent Pericarditis
- Phase
- Phase 1
- Modality
- other
- Status
- active